Lupin Recalls Escitalopram Tablets Due to Incorrect or Missing Lot and Expiration Dates
Lupin Limited is recalling 3,192 bottles of Escitalopram Tablets USP 20 mg because the labels may have incorrect or missing lot and expiration dates.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The hazard is limited to a documentation and labeling issue.
Plain-English summary
Lupin Limited is recalling 3,192 bottles of Escitalopram Tablets USP 20 mg, 100-count bottles, due to labeling errors. The recall is limited to Lot # G510086 with an expiration date of 11/17. The product is distributed nationwide.
The recall was initiated because the product labels may contain incorrect or missing lot and/or expiration date information. This labeling issue could affect the ability to track the product or verify its expiration status.
Consumers who have this specific lot of Escitalopram Tablets should contact their healthcare provider or pharmacist for guidance on how to proceed. The product is a prescription-only medication manufactured by Lupin Limited in India for Lupin Pharmaceuticals in Baltimore, MD.
The recalled product
- Product
- ESCITALOPRAM (ESCITSLOPRAM)
- Brand
- ESCITALOPRAM
- Manufacturer
- Lupin Limited
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # G510086
- Exp. 11/17
UPCs (2)
- 0368180135012
- 0368180136019
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Lupin Limited
See all →- ModerateLupin Recalls Pravastatin Sodium Tablets Due to Foreign Capsule Presence
FDA (Drugs) · 2017-11-29
- ModerateLupin Recalls Amlodipine Besylate Tablets Due to CGMP Deviations
FDA (Drugs) · 2016-09-14
- LowLupin Recalls Amlodipine Besylate Tablets Due to CGMP Deviations
FDA (Drugs) · 2016-09-14
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateLupin Recalls 20 mg Lisinopril Tablets Due to Product Mix-Up
FDA (Drugs) · 2020-04-29
- ModerateLupin Recalls Lisinopril Tablets Due to CGMP Deviations
FDA (Drugs) · 2016-09-28
- HighLupin Recalls Lisinopril 5 mg Tablets Due to Product Mix-Up
FDA (Drugs) · 2020-06-17
- LowLupin Recalls Hydrocodone and Acetaminophen Tablets for Missing Labels
FDA (Drugs) · 2018-06-06
- HighLupin Recalls Lisinopril Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2020-08-05
- LowPfizer Recalls Ethosuximide Capsules Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2019-10-02